Actionable news
0
All posts from Actionable news
Actionable news in RXDX: IGNYTA INC,

BRIEF-Ignyta receives FDA orphan drug designation for entrectinib

Ignyta Inc:

* Ignyta receives FDA orphan drug designation for entrectinib for treatment of NTRK fusion-positive solid tumors

* Ignyta Inc - ‍FDA has granted orphan drug designation to entrectinib​...


More